New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
07:06 EDTTBIOTransgenomic enters agreement with DNA Technologies
Transgenomic announced that it has entered into an agreement to sell to Integrated DNA Technologies the rights to Transgenomic’s SURVEYOR Nuclease technology and assets for a minimum of $4.25M. Under the terms of the agreement, IDT will make an upfront payment of $3.65M and additional minimum payments of $0.6M or more to Transgenomic during the first year of the agreement. Transgenomic will transfer rights to the SURVEYOR patents, license, technology, know-how and trademarks to IDT, as well as all inventory of the product. As part of the agreement, IDT will exclusively sublicense rights for all clinical and diagnostic applications of the SURVEYOR technology back to Transgenomic. Further terms of the agreement were not disclosed.
News For TBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
09:11 EDTTBIOTransgenomic 3.574M share Secondary priced at $1.95
Craig-Hallum acted as sole book running manager for the offering.
06:33 EDTTBIOTransgenomic raises $6.2M through an equity offering
Subscribe for More Information
February 26, 2015
17:10 EDTTBIOTransgenomic Inc files automatic common stock shelf
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use